Results 91 to 100 of about 8,114 (132)

Hospital Radiopharmacy in Argentina during the COVID-19 pandemic. Criteria and rationale for the organization of work. [PDF]

open access: yesRev Esp Med Nucl Imagen Mol (Engl Ed), 2020
Rabiller G   +5 more
europepmc   +1 more source

Ganglio centinela para estadios tempranos en cáncer de cuello uterino

open access: yes, 2012
Objectives: To determine sentinel node (SN) detection feasibility and safety by using lymphatic mapping with 99m Tc dextran and injection of blue dye (patent blue) in patients with early cervical cáncer undergoing radical hysterectomy with bilateral ...
Valdivia, Henry   +9 more
core  

[Merkel cell carcinoma: current surgical approaches and multidisciplinary treatment]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Romero-López A   +4 more
europepmc   +1 more source

Protocolo clínico para la validación de la técnica selectiva del ganglio centinela

open access: yes, 2015
Tesis (especialidad en ginecología y obstetricia)--Universidad de Costa Rica. Sistema de Estudios de Posgrado, 2015La resección de los ganglios centinelas (los primeros ganglios que reciben drenaje de un tumor) identifican la presencia de metástasis ...
Sánchez Ortega, María Melania   +1 more
core  

[Eccrine porocarcinoma on the dorsum of the foot: case report of a rare tumor] [PDF]

open access: yesRev Fac Cien Med Univ Nac Cordoba
Sanguinetti J   +4 more
europepmc   +1 more source

Clinicopathological factors associated with sentinel lymph node positivity in breast cancer using indocyanine green: a retrospective study in Peru. [PDF]

open access: yesWorld J Surg Oncol
Mendoza De Lama GW   +9 more
europepmc   +1 more source

[Artículo traducido] Biopsia del ganglio centinela en pacientes mayores con melanoma: cohorte en la práctica real

open access: yesActas Dermo-Sifiliográficas, 2023
P. Rodríguez-Jiménez   +10 more
doaj   +1 more source

[Metastatic breast melanoma in a man: Case report]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Suro-Santos Y   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy